Skip to content

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

AdminJun 26, 2019< 1 min read

Real-world evidence: The future is here

As part of a series of articles produced in association with Cytel, pharmaphorum’s Richard Staines spoke with Jeremy Rassen, (President and Chief Science Officer at Aetion) about how data obtained from outside the traditional randomized controlled trial setting is transforming drug research.

Read More

RELATED ARTICLES